| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Keenen Terrence | Director | C/O LEGENCE CORP., 1601 LAS PLUMAS AVENUE, SAN JOSE | /s/ Bryce Seki, as attorney-in-fact | 15 Sep 2025 | 0002082078 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LGN | Class A Common Stock | Purchase | $249,984 | +8,928 | $28.00 | 8,928 | 15 Sep 2025 | Direct | F1 | |
| transaction | LGN | Class A Common Stock | Award | $0 | +5,357 | +60% | $0.000000 | 14,285 | 15 Sep 2025 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | The reported securities were purchased through a directed share program in connection with Legence Corp.'s (the "Issuer") initial public offering. |
| F2 | The reported securities represent an award of Restricted Stock Units, which each entitle the reporting person to receive one share of the Issuer's Class A common stock, par value $0.01 per share, upon vesting. The Restricted Stock Units will fully vest on the earlier of the first anniversary of the date of the award and the day immediately preceding the Issuer's 2026 annual stockholder meeting, subject to continued service through such date. |